Last week our scientific director dr. Peter van Dam had the privilege
to present the added value of both our CineECG and our MORE2C technology
to a group of groundbreaking innovators in the domain of genetic cardiac diseases
detection and monitoring. The team from our research partner UMCU presented the results in monitoring and selecting high risk ARVC patients. Peter showed the first results in using CIneECG for detecting changes is P waves. To support the identification of very early stages of AFib.
We thank the team of UMCU and the Dutch Heart Foundation for supporting our work. And a big thank you to prof. Pyotr Platonov and his team for organizing the Trolleholm Cardiogenetic Conference.
#cardiology #digitalhealthcare #electrocardiogram #ECG #EKG #electrophysiology #diagnostics #healthcare #medtech #innovation #ARVC #Ischemia #Cardiogenetics #DutchHeartFoundation #CineECG
Share our website